Browse by Author Kallender, H
|
|
|
|
|
| Title | Author(s) | Year | View Count |  | A Phase I/II study of foretinib, an oral multikinase inhibitor targeting MET, RON, AXL, TIE-2 and VEGFR in advanced hepatocellular carcinoma (HCC) | Yau, T; Yen, CJ; Chen, PJ; Chau, Y; Lencioni, R; Kallender, H; Ottesen, LH; Poon, RTP | 2011 | 247 |
| A phase I/II study of Foretinib, an oral multikinase inhibitor targeting MET, RON, AXL, TIE-2 and VEGFR in advanced hepatocellular carcinoma (HCC) | Yau, TCC; Sukeepaisarnjaroen, W; Chao, Y; Yen, CJ; Lausoontornsiri, W; Chen, PJ; Sanpajit, T; Lencioni, R; Camp, A; Kallender, H; Ottesen, LH; Poon, RTP | 2011 | 74 |
|
|
|
|
